Calcitonin Gene–Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine
This study provides Class II evidence that in patients with migraine, initiation of a CGRP inhibitor was associated with a modestly increased risk of a composite of cardiovascular events.
Authors
- Carlene Moore
- Jay B. Lusk (ORCID: https://orcid.org/0000-0002-5728-8872)
- Brian Mac Grory (ORCID: https://orcid.org/0000-0003-3914-8419)
- Stephanie Yarnell
- Aparna Choudhury (ORCID: https://orcid.org/0000-0002-6916-0681)
- Lauren E. Wilson (ORCID: https://orcid.org/0000-0002-5953-2293)
- Matthew Schrag (ORCID: https://orcid.org/0000-0001-7048-0503)
- Li Fan (ORCID: https://orcid.org/0000-0001-7812-6111)
- Cheryl Kalapura
- Sven Poli
Institutions
- University of North Carolina at Chapel Hill (US)
- Duke University (US)
- Vanderbilt University (US)
- Yale University (US)
- Clinical Research Institute (US)
- Hertie Institute for Clinical Brain Research (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- Neurology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1212/wnl.0000000000214479
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 33.12